Tubal Ligation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Minimal effective dose of ultrasound-guided rectus sheath block to reduce oral analgesic requirement after ambulatory laparoscopic tubal resection: a randomized controlled superiority trial
ConclusionA dose of 0.25% bupivacaine 50  mg for URSB reduced the oral analgesic requirement at 24 h and prolonged the time to first analgesic requirement after ambulatory laparoscopic tubal resection.Trial registrationThaiclinicaltrials.orgTCTR20150921002. Registered on 18 September 2015 (Source: Trials)
Source: Trials - March 21, 2022 Category: Research Source Type: clinical trials

ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)
Condition:   Pain Intervention:   Drug: Hyperbaric bupivacaine Sponsor:   Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2021 Category: Research Source Type: clinical trials